Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Adding Quercetin or Alpha Lipoic Acid as an Adjuvant Therapy on Clinical and Biochemical Outcomes in a Sample of Iraqi PCOS Patients

NCT07182526 is registered in ClinicalTrials.gov with Al-Mustansiriyah University as lead sponsor.

NCT NCT07182526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07182526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Adding Quercetin or Alpha Lipoic Acid as an Adjuvant Therapy on Clinical and Biochemical Outcomes in a Sample of Iraqi PCOS Patients
Lead sponsor
Al-Mustansiriyah University
Phase
Phase 2
Overall status
Recruiting
Start date
September 20, 2025
Completion date
May 1, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pcos (polycystic ovary syndrome) of bilateral ovaries